Posts

Showing posts from November, 2023

North America Contributes Major Share in Primary Care Physicians Market

Image
Primary Care Physicians Market The global Primary Care Physicians Market is estimated to be valued at US$ 701.20 billion in 2022 and is expected to exhibit a CAGR of 4.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Primary care physicians provide a variety of healthcare services including health assessments, treatment of acute and chronic illnesses, immunizations, and other preventative services. They help enhance patient outcomes through preventative care and reducing unnecessary emergency room visits and hospitalizations. Market key trends: One of the key trends in the primary care physicians market is growing adoption of telehealth. The COVID-19 pandemic accelerated the use of telehealth as it allowed patients to connect with physicians virtually without visiting clinics physically. Various primary care providers are offering telehealth consultations to expand access and enhance convenience. This tre

Africa Bitumen Market Share

Image
Africa Bitumen Market  The Africa Bitumen Market is estimated to be valued at US$ 418.71 Mn in 2022 and is expected to exhibit a CAGR of 5.3% over the forecast period, 2021 to 2028, as highlighted in a new report published by Coherent Market Insights. Market Overview: Bitumen is a sticky, black and highly viscous liquid or semi-solid form of petroleum. Bitumen is commonly used for roads and roof construction due to its excellent waterproofing and adhesion properties. It provides strong, durable and cost-effective constructions. Market key trends: One of the major trends witnessed in the Africa bitumen market is growing infrastructure development activities. There is significant growth in construction of new roads, highways, rail networks and airports in the region. Various governments in Africa are investing heavily in infrastructure upgrade and development projects. For instance, Ethiopia plans to construct thousands of kilometers of new roads over the coming years to support its gr

India Advanced Wound Care Management market Skin Care segment contributing large share

Image
India Advanced Wound Care Management market  The global India Advanced Wound Care Management market is estimated to be valued at US$ 276.3 million in 2022 and is expected to exhibit a CAGR of 5.1% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Advanced wound care management products help in faster healing of chronic and acute wounds. These products maintain a moist environment which facilitates cell migration and tissue remodeling for wound repair. Market key trends: The advanced wound care management market in India is witnessing increasing adoption of advanced wound care products such as silver wound dressings. Silver has anti-microbial properties and silver dressings helps in preventing wound infections by releasing silver ions. These dressing inhibits the growth of bacteria, yeast, and viruses and maintains a moist healing environment. Hence, the increasing use of silver based wound care dressings is expe

Biopharmaceutical and Biomedicine Market Contributing Large Share

Image
Biopharmaceutical and Biomedicine Market The global Biopharmaceutical and Biomedicine Market is estimated to be valued at US$ 561,375.9 million in 2022 and is expected to exhibit a CAGR of 9.6% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Biopharmaceuticals and biomedicine products play an important role in treating various diseases and provide improved quality of life. These products are being used for treatment of cancer, metabolic disorders, cardiovascular diseases, infectious diseases and others. Biopharmaceuticals offer targeted therapy with minimum side effects. Market key trends: One of the key trend in the Biopharmaceutical and Biomedicine Market is the increasing R&D investments in cell and gene therapy. Biopharmaceutical companies are investing significantly in development of new cell and gene therapies to treat various genetic and chronic diseases. For instance, Novartis invested around US$ 5